nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—AVPR1A—Vasopressin-like receptors—OXT—germ cell cancer	0.0979	0.209	CbGpPWpGaD
Conivaptan—AVPR2—Vasopressin-like receptors—OXT—germ cell cancer	0.0972	0.207	CbGpPWpGaD
Conivaptan—AVPR1A—Vasopressin-like receptors—AVP—germ cell cancer	0.0671	0.143	CbGpPWpGaD
Conivaptan—AVPR2—Vasopressin-like receptors—AVP—germ cell cancer	0.0666	0.142	CbGpPWpGaD
Conivaptan—AVPR2—urine—germ cell cancer	0.0315	0.492	CbGeAlD
Conivaptan—Arrhythmia supraventricular—Ifosfamide—germ cell cancer	0.0185	0.0396	CcSEcCtD
Conivaptan—AVPR2—Vasopressin regulates renal water homeostasis via Aquaporins—AVP—germ cell cancer	0.0138	0.0294	CbGpPWpGaD
Conivaptan—Hypomagnesaemia—Bleomycin—germ cell cancer	0.0132	0.0283	CcSEcCtD
Conivaptan—AVPR2—Aquaporin-mediated transport—AVP—germ cell cancer	0.012	0.0256	CbGpPWpGaD
Conivaptan—Phlebitis—Vinblastine—germ cell cancer	0.00838	0.0179	CcSEcCtD
Conivaptan—AVPR1A—adrenal gland—germ cell cancer	0.00726	0.113	CbGeAlD
Conivaptan—Phlebitis—Bleomycin—germ cell cancer	0.00708	0.0151	CcSEcCtD
Conivaptan—Sepsis—Dactinomycin—germ cell cancer	0.0068	0.0145	CcSEcCtD
Conivaptan—Phlebitis—Dactinomycin—germ cell cancer	0.0066	0.0141	CcSEcCtD
Conivaptan—Urine output increased—Ifosfamide—germ cell cancer	0.00649	0.0139	CcSEcCtD
Conivaptan—AVPR1A—endocrine gland—germ cell cancer	0.0063	0.0984	CbGeAlD
Conivaptan—AVPR1A—G alpha (q) signalling events—OXT—germ cell cancer	0.00625	0.0133	CbGpPWpGaD
Conivaptan—Sepsis—Ifosfamide—germ cell cancer	0.00623	0.0133	CcSEcCtD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—OXT—germ cell cancer	0.00617	0.0132	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—OXT—germ cell cancer	0.00612	0.0131	CbGpPWpGaD
Conivaptan—Phlebitis—Ifosfamide—germ cell cancer	0.00605	0.0129	CcSEcCtD
Conivaptan—Polyuria—Ifosfamide—germ cell cancer	0.00594	0.0127	CcSEcCtD
Conivaptan—AVPR2—G alpha (s) signalling events—AVP—germ cell cancer	0.0059	0.0126	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	0.00559	0.0119	CbGpPWpGaD
Conivaptan—Atrial fibrillation—Ifosfamide—germ cell cancer	0.0055	0.0118	CcSEcCtD
Conivaptan—AVPR2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.0055	0.0117	CbGpPWpGaD
Conivaptan—Candida infection—Etoposide—germ cell cancer	0.00541	0.0116	CcSEcCtD
Conivaptan—Cardiac failure—Ifosfamide—germ cell cancer	0.00534	0.0114	CcSEcCtD
Conivaptan—Phlebitis—Cisplatin—germ cell cancer	0.00522	0.0112	CcSEcCtD
Conivaptan—AVPR2—head—germ cell cancer	0.00515	0.0805	CbGeAlD
Conivaptan—Polyuria—Cisplatin—germ cell cancer	0.00512	0.0109	CcSEcCtD
Conivaptan—Sepsis—Etoposide—germ cell cancer	0.00492	0.0105	CcSEcCtD
Conivaptan—CYP3A4—urine—germ cell cancer	0.00479	0.0749	CbGeAlD
Conivaptan—Phlebitis—Etoposide—germ cell cancer	0.00478	0.0102	CcSEcCtD
Conivaptan—Hypokalaemia—Ifosfamide—germ cell cancer	0.00474	0.0101	CcSEcCtD
Conivaptan—Pneumonia—Bleomycin—germ cell cancer	0.00473	0.0101	CcSEcCtD
Conivaptan—Hyponatraemia—Cisplatin—germ cell cancer	0.00451	0.00965	CcSEcCtD
Conivaptan—AVPR1A—brain—germ cell cancer	0.0045	0.0704	CbGeAlD
Conivaptan—Haematuria—Bleomycin—germ cell cancer	0.00448	0.00959	CcSEcCtD
Conivaptan—Pneumonia—Dactinomycin—germ cell cancer	0.00441	0.00943	CcSEcCtD
Conivaptan—AVPR1A—G alpha (q) signalling events—AVP—germ cell cancer	0.00428	0.00914	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—AVP—germ cell cancer	0.00423	0.00902	CbGpPWpGaD
Conivaptan—Cardiac failure—Etoposide—germ cell cancer	0.00422	0.00903	CcSEcCtD
Conivaptan—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	0.0042	0.00896	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—AVP—germ cell cancer	0.0042	0.00896	CbGpPWpGaD
Conivaptan—Dehydration—Cisplatin—germ cell cancer	0.00418	0.00894	CcSEcCtD
Conivaptan—Pollakiuria—Ifosfamide—germ cell cancer	0.00416	0.0089	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.00414	0.00883	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.00411	0.00876	CbGpPWpGaD
Conivaptan—Orthostatic hypotension—Cisplatin—germ cell cancer	0.0041	0.00878	CcSEcCtD
Conivaptan—Hypokalaemia—Cisplatin—germ cell cancer	0.00409	0.00875	CcSEcCtD
Conivaptan—Hyperglycaemia—Ifosfamide—germ cell cancer	0.00406	0.0087	CcSEcCtD
Conivaptan—Pneumonia—Ifosfamide—germ cell cancer	0.00404	0.00864	CcSEcCtD
Conivaptan—Anaemia—Vinblastine—germ cell cancer	0.00402	0.0086	CcSEcCtD
Conivaptan—Infestation—Ifosfamide—germ cell cancer	0.00402	0.00859	CcSEcCtD
Conivaptan—Infestation NOS—Ifosfamide—germ cell cancer	0.00402	0.00859	CcSEcCtD
Conivaptan—Haematuria—Ifosfamide—germ cell cancer	0.00383	0.00819	CcSEcCtD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	0.00383	0.00817	CbGpPWpGaD
Conivaptan—Hypertension—Vinblastine—germ cell cancer	0.00375	0.00803	CcSEcCtD
Conivaptan—AVPR2—brain—germ cell cancer	0.00373	0.0583	CbGeAlD
Conivaptan—Erythema—Bleomycin—germ cell cancer	0.00367	0.00786	CcSEcCtD
Conivaptan—AVPR2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.0036	0.00768	CbGpPWpGaD
Conivaptan—Urinary tract disorder—Ifosfamide—germ cell cancer	0.00356	0.00762	CcSEcCtD
Conivaptan—AVPR2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.00354	0.00756	CbGpPWpGaD
Conivaptan—Urethral disorder—Ifosfamide—germ cell cancer	0.00353	0.00756	CcSEcCtD
Conivaptan—Erythema—Dactinomycin—germ cell cancer	0.00343	0.00733	CcSEcCtD
Conivaptan—Anaemia—Bleomycin—germ cell cancer	0.00339	0.00726	CcSEcCtD
Conivaptan—Cardiac disorder—Ifosfamide—germ cell cancer	0.00335	0.00716	CcSEcCtD
Conivaptan—Angiopathy—Ifosfamide—germ cell cancer	0.00327	0.007	CcSEcCtD
Conivaptan—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00325	0.00695	CcSEcCtD
Conivaptan—Pneumonia—Etoposide—germ cell cancer	0.00319	0.00683	CcSEcCtD
Conivaptan—Infestation NOS—Etoposide—germ cell cancer	0.00317	0.00679	CcSEcCtD
Conivaptan—Infestation—Etoposide—germ cell cancer	0.00317	0.00679	CcSEcCtD
Conivaptan—Anaemia—Dactinomycin—germ cell cancer	0.00317	0.00677	CcSEcCtD
Conivaptan—Mental disorder—Ifosfamide—germ cell cancer	0.00316	0.00676	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—OXT—germ cell cancer	0.00315	0.00672	CbGpPWpGaD
Conivaptan—Erythema—Ifosfamide—germ cell cancer	0.00314	0.00672	CcSEcCtD
Conivaptan—Malnutrition—Ifosfamide—germ cell cancer	0.00314	0.00672	CcSEcCtD
Conivaptan—AVPR2—GPCR ligand binding—OXT—germ cell cancer	0.00313	0.00667	CbGpPWpGaD
Conivaptan—Urine output increased—Methotrexate—germ cell cancer	0.00307	0.00657	CcSEcCtD
Conivaptan—Urinary tract disorder—Cisplatin—germ cell cancer	0.00307	0.00657	CcSEcCtD
Conivaptan—Urethral disorder—Cisplatin—germ cell cancer	0.00305	0.00652	CcSEcCtD
Conivaptan—Constipation—Vinblastine—germ cell cancer	0.00304	0.00649	CcSEcCtD
Conivaptan—Pain—Vinblastine—germ cell cancer	0.00304	0.00649	CcSEcCtD
Conivaptan—Confusional state—Bleomycin—germ cell cancer	0.00302	0.00647	CcSEcCtD
Conivaptan—Infection—Bleomycin—germ cell cancer	0.00298	0.00637	CcSEcCtD
Conivaptan—Sepsis—Methotrexate—germ cell cancer	0.00295	0.00631	CcSEcCtD
Conivaptan—Feeling abnormal—Vinblastine—germ cell cancer	0.00292	0.00626	CcSEcCtD
Conivaptan—Anaemia—Ifosfamide—germ cell cancer	0.0029	0.00621	CcSEcCtD
Conivaptan—Cardiac disorder—Cisplatin—germ cell cancer	0.00289	0.00617	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.00284	0.00605	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.00282	0.00601	CbGpPWpGaD
Conivaptan—Urinary tract disorder—Etoposide—germ cell cancer	0.00281	0.00602	CcSEcCtD
Conivaptan—Polyuria—Methotrexate—germ cell cancer	0.00281	0.00601	CcSEcCtD
Conivaptan—Mediastinal disorder—Cisplatin—germ cell cancer	0.0028	0.00599	CcSEcCtD
Conivaptan—Hypotension—Bleomycin—germ cell cancer	0.0028	0.00599	CcSEcCtD
Conivaptan—Urethral disorder—Etoposide—germ cell cancer	0.00279	0.00597	CcSEcCtD
Conivaptan—Infection—Dactinomycin—germ cell cancer	0.00278	0.00594	CcSEcCtD
Conivaptan—Hypertension—Ifosfamide—germ cell cancer	0.00271	0.0058	CcSEcCtD
Conivaptan—Malnutrition—Cisplatin—germ cell cancer	0.00271	0.00579	CcSEcCtD
Conivaptan—Erythema—Cisplatin—germ cell cancer	0.00271	0.00579	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00265	0.00568	CcSEcCtD
Conivaptan—Cardiac disorder—Etoposide—germ cell cancer	0.00264	0.00566	CcSEcCtD
Conivaptan—Angiopathy—Etoposide—germ cell cancer	0.00258	0.00553	CcSEcCtD
Conivaptan—Confusional state—Ifosfamide—germ cell cancer	0.00258	0.00553	CcSEcCtD
Conivaptan—Mediastinal disorder—Etoposide—germ cell cancer	0.00257	0.00549	CcSEcCtD
Conivaptan—Pain—Bleomycin—germ cell cancer	0.00256	0.00548	CcSEcCtD
Conivaptan—Infection—Ifosfamide—germ cell cancer	0.00255	0.00545	CcSEcCtD
Conivaptan—Nervous system disorder—Ifosfamide—germ cell cancer	0.00251	0.00538	CcSEcCtD
Conivaptan—Anaemia—Cisplatin—germ cell cancer	0.0025	0.00535	CcSEcCtD
Conivaptan—Skin disorder—Ifosfamide—germ cell cancer	0.00249	0.00532	CcSEcCtD
Conivaptan—Feeling abnormal—Bleomycin—germ cell cancer	0.00247	0.00529	CcSEcCtD
Conivaptan—Diarrhoea—Vinblastine—germ cell cancer	0.00243	0.0052	CcSEcCtD
Conivaptan—Hypotension—Ifosfamide—germ cell cancer	0.00239	0.00512	CcSEcCtD
Conivaptan—Pain—Dactinomycin—germ cell cancer	0.00239	0.00512	CcSEcCtD
Conivaptan—Body temperature increased—Bleomycin—germ cell cancer	0.00237	0.00507	CcSEcCtD
Conivaptan—Feeling abnormal—Dactinomycin—germ cell cancer	0.0023	0.00493	CcSEcCtD
Conivaptan—Anaemia—Etoposide—germ cell cancer	0.00229	0.0049	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00229	0.0049	CcSEcCtD
Conivaptan—Vomiting—Vinblastine—germ cell cancer	0.00226	0.00483	CcSEcCtD
Conivaptan—Headache—Vinblastine—germ cell cancer	0.00222	0.00476	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00221	0.00473	CcSEcCtD
Conivaptan—Body temperature increased—Dactinomycin—germ cell cancer	0.00221	0.00473	CcSEcCtD
Conivaptan—Infection—Cisplatin—germ cell cancer	0.00219	0.00469	CcSEcCtD
Conivaptan—Pain—Ifosfamide—germ cell cancer	0.00219	0.00469	CcSEcCtD
Conivaptan—Constipation—Ifosfamide—germ cell cancer	0.00219	0.00469	CcSEcCtD
Conivaptan—Nervous system disorder—Cisplatin—germ cell cancer	0.00217	0.00463	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—AVP—germ cell cancer	0.00216	0.00461	CbGpPWpGaD
Conivaptan—Skin disorder—Cisplatin—germ cell cancer	0.00215	0.00459	CcSEcCtD
Conivaptan—AVPR2—GPCR ligand binding—AVP—germ cell cancer	0.00214	0.00457	CbGpPWpGaD
Conivaptan—Hypertension—Etoposide—germ cell cancer	0.00214	0.00458	CcSEcCtD
Conivaptan—Pruritus—Bleomycin—germ cell cancer	0.00212	0.00454	CcSEcCtD
Conivaptan—Feeling abnormal—Ifosfamide—germ cell cancer	0.00211	0.00452	CcSEcCtD
Conivaptan—Nausea—Vinblastine—germ cell cancer	0.00211	0.00451	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.0021	0.00448	CcSEcCtD
Conivaptan—Hypotension—Cisplatin—germ cell cancer	0.00206	0.00442	CcSEcCtD
Conivaptan—Confusional state—Etoposide—germ cell cancer	0.00204	0.00437	CcSEcCtD
Conivaptan—Body temperature increased—Ifosfamide—germ cell cancer	0.00203	0.00433	CcSEcCtD
Conivaptan—Infection—Etoposide—germ cell cancer	0.00201	0.0043	CcSEcCtD
Conivaptan—Skin disorder—Etoposide—germ cell cancer	0.00197	0.00421	CcSEcCtD
Conivaptan—Diarrhoea—Dactinomycin—germ cell cancer	0.00191	0.00409	CcSEcCtD
Conivaptan—Pneumonia—Methotrexate—germ cell cancer	0.00191	0.00409	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00191	0.00408	CcSEcCtD
Conivaptan—Vomiting—Bleomycin—germ cell cancer	0.00191	0.00408	CcSEcCtD
Conivaptan—Infestation NOS—Methotrexate—germ cell cancer	0.0019	0.00407	CcSEcCtD
Conivaptan—Infestation—Methotrexate—germ cell cancer	0.0019	0.00407	CcSEcCtD
Conivaptan—Hypotension—Etoposide—germ cell cancer	0.00189	0.00405	CcSEcCtD
Conivaptan—Pain—Cisplatin—germ cell cancer	0.00189	0.00404	CcSEcCtD
Conivaptan—Feeling abnormal—Cisplatin—germ cell cancer	0.00182	0.00389	CcSEcCtD
Conivaptan—Pruritus—Ifosfamide—germ cell cancer	0.00181	0.00388	CcSEcCtD
Conivaptan—Haematuria—Methotrexate—germ cell cancer	0.00181	0.00388	CcSEcCtD
Conivaptan—Nausea—Bleomycin—germ cell cancer	0.00178	0.00381	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—OXT—germ cell cancer	0.00178	0.0038	CbGpPWpGaD
Conivaptan—Vomiting—Dactinomycin—germ cell cancer	0.00178	0.0038	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—OXT—germ cell cancer	0.00177	0.00377	CbGpPWpGaD
Conivaptan—Diarrhoea—Ifosfamide—germ cell cancer	0.00175	0.00375	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00175	0.00374	CcSEcCtD
Conivaptan—Body temperature increased—Cisplatin—germ cell cancer	0.00175	0.00374	CcSEcCtD
Conivaptan—Pain—Etoposide—germ cell cancer	0.00173	0.0037	CcSEcCtD
Conivaptan—Constipation—Etoposide—germ cell cancer	0.00173	0.0037	CcSEcCtD
Conivaptan—Urinary tract disorder—Methotrexate—germ cell cancer	0.00168	0.0036	CcSEcCtD
Conivaptan—Urethral disorder—Methotrexate—germ cell cancer	0.00167	0.00358	CcSEcCtD
Conivaptan—Feeling abnormal—Etoposide—germ cell cancer	0.00167	0.00357	CcSEcCtD
Conivaptan—Nausea—Dactinomycin—germ cell cancer	0.00166	0.00355	CcSEcCtD
Conivaptan—AVPR2—Transmembrane transport of small molecules—AVP—germ cell cancer	0.00166	0.00354	CbGpPWpGaD
Conivaptan—Vomiting—Ifosfamide—germ cell cancer	0.00163	0.00349	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—OXT—germ cell cancer	0.00162	0.00345	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—OXT—germ cell cancer	0.00161	0.00343	CbGpPWpGaD
Conivaptan—Body temperature increased—Etoposide—germ cell cancer	0.0016	0.00342	CcSEcCtD
Conivaptan—Cardiac disorder—Methotrexate—germ cell cancer	0.00158	0.00339	CcSEcCtD
Conivaptan—Angiopathy—Methotrexate—germ cell cancer	0.00155	0.00331	CcSEcCtD
Conivaptan—Mediastinal disorder—Methotrexate—germ cell cancer	0.00154	0.00329	CcSEcCtD
Conivaptan—Nausea—Ifosfamide—germ cell cancer	0.00152	0.00326	CcSEcCtD
Conivaptan—Diarrhoea—Cisplatin—germ cell cancer	0.00151	0.00323	CcSEcCtD
Conivaptan—Mental disorder—Methotrexate—germ cell cancer	0.00149	0.0032	CcSEcCtD
Conivaptan—Malnutrition—Methotrexate—germ cell cancer	0.00148	0.00318	CcSEcCtD
Conivaptan—Erythema—Methotrexate—germ cell cancer	0.00148	0.00318	CcSEcCtD
Conivaptan—Pruritus—Etoposide—germ cell cancer	0.00143	0.00306	CcSEcCtD
Conivaptan—Vomiting—Cisplatin—germ cell cancer	0.0014	0.003	CcSEcCtD
Conivaptan—Diarrhoea—Etoposide—germ cell cancer	0.00138	0.00296	CcSEcCtD
Conivaptan—Anaemia—Methotrexate—germ cell cancer	0.00137	0.00294	CcSEcCtD
Conivaptan—Nausea—Cisplatin—germ cell cancer	0.00131	0.00281	CcSEcCtD
Conivaptan—Vomiting—Etoposide—germ cell cancer	0.00129	0.00275	CcSEcCtD
Conivaptan—Headache—Etoposide—germ cell cancer	0.00127	0.00271	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.00126	0.00269	CcSEcCtD
Conivaptan—Confusional state—Methotrexate—germ cell cancer	0.00122	0.00261	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—AVP—germ cell cancer	0.00122	0.0026	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—AVP—germ cell cancer	0.00121	0.00259	CbGpPWpGaD
Conivaptan—Infection—Methotrexate—germ cell cancer	0.0012	0.00258	CcSEcCtD
Conivaptan—Nausea—Etoposide—germ cell cancer	0.0012	0.00257	CcSEcCtD
Conivaptan—Nervous system disorder—Methotrexate—germ cell cancer	0.00119	0.00254	CcSEcCtD
Conivaptan—Skin disorder—Methotrexate—germ cell cancer	0.00118	0.00252	CcSEcCtD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	0.00116	0.00247	CbGpPWpGaD
Conivaptan—Hypotension—Methotrexate—germ cell cancer	0.00113	0.00242	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—AVP—germ cell cancer	0.00111	0.00236	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—AVP—germ cell cancer	0.0011	0.00235	CbGpPWpGaD
Conivaptan—Insomnia—Methotrexate—germ cell cancer	0.0011	0.00235	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.00105	0.00224	CcSEcCtD
Conivaptan—Pain—Methotrexate—germ cell cancer	0.00104	0.00222	CcSEcCtD
Conivaptan—Feeling abnormal—Methotrexate—germ cell cancer	0.000999	0.00214	CcSEcCtD
Conivaptan—Body temperature increased—Methotrexate—germ cell cancer	0.000958	0.00205	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—OXT—germ cell cancer	0.000955	0.00204	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—OXT—germ cell cancer	0.000948	0.00202	CbGpPWpGaD
Conivaptan—Pruritus—Methotrexate—germ cell cancer	0.000857	0.00183	CcSEcCtD
Conivaptan—Diarrhoea—Methotrexate—germ cell cancer	0.000829	0.00177	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—FGF4—germ cell cancer	0.000815	0.00174	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FGF4—germ cell cancer	0.000809	0.00173	CbGpPWpGaD
Conivaptan—CYP3A4—endocrine gland—germ cell cancer	0.000794	0.0124	CbGeAlD
Conivaptan—Vomiting—Methotrexate—germ cell cancer	0.000771	0.00165	CcSEcCtD
Conivaptan—Headache—Methotrexate—germ cell cancer	0.000759	0.00162	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—H2AFZ—germ cell cancer	0.000728	0.00155	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—H2AFZ—germ cell cancer	0.000723	0.00154	CbGpPWpGaD
Conivaptan—Nausea—Methotrexate—germ cell cancer	0.00072	0.00154	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—KITLG—germ cell cancer	0.00067	0.00143	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—KITLG—germ cell cancer	0.000665	0.00142	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AVP—germ cell cancer	0.000655	0.0014	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AVP—germ cell cancer	0.00065	0.00139	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FGFR3—germ cell cancer	0.000498	0.00106	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FGFR3—germ cell cancer	0.000494	0.00105	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—KIT—germ cell cancer	0.000457	0.000975	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—KIT—germ cell cancer	0.000454	0.000968	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HRAS—germ cell cancer	0.000334	0.000713	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HRAS—germ cell cancer	0.000332	0.000708	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MYC—germ cell cancer	0.000251	0.000537	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MYC—germ cell cancer	0.00025	0.000533	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TP53—germ cell cancer	0.000207	0.000441	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TP53—germ cell cancer	0.000205	0.000437	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC2A3—germ cell cancer	0.000198	0.000422	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HRAS—germ cell cancer	0.000198	0.000421	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HRAS—germ cell cancer	0.000196	0.000418	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC22A3—germ cell cancer	0.000195	0.000416	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CRABP1—germ cell cancer	0.000159	0.000339	CbGpPWpGaD
